Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P285 | DOI: 10.1530/endoabs.110.P285

ECEESPE2025 Poster Presentations Bone and Mineral Metabolism (112 abstracts)

Biochemical response kinetics in vitamin d resistant rickets (VDDR) type 1 and 2: 13-year retrospective analysis from a tertiary care centre

Archana K 1 , Preeti Dabadghao 1 , Vijayalakshmi Bhatia 1 & Archana Kumari 1


1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Endocrinology, Lucknow, India


JOINT168

Background: Vitamin D-resistant rickets (VDDR) type 1 and 2 are rare genetic forms of rickets. A few genetically proven cases have been reported from India. The pragmatic treatment responses assessed over time in literature are scarce.

Method: Retrospectively, we identified a cohort of fifteen cases of VDDR, including 6 patients of VDDR 1A, 2 patients of VDDR 1B, 7 patients of VDDR 2. The biochemical parameters, treatment and outcomes were analyzed. Data are presented as median with inter-quartile range (IQR), and mixed effect analysis for statistical analysis was used.

Result: In VDDR1A, the median age of presentation and delay in diagnosis was 12 (IQR-8-13. 5) and 26 months, whereas for VDDR2 it was 12 (IQR-6-24) and 46 months (6-58) respectively. 50% of VDDR1A patients had severe calcipenic symptoms and serum calcium improved over time from baseline- 7. 75mg/dl to 9. 3mg/dl at 1 year, and 9. 9mg/dl at 5 years, requiring a calcium dose(mg/kg/d) of 62. 5(44-128. 75), which reduced to 26. 5(18. 5-56. 25). Likewise, calcitriol dose (ng/kg/d) reduced from 40(26. 25-63. 75) to 24(12. 5-30. 75). In VDDR2, alopecia was present in 6 out of 7 patients, however only 28. 6% had severe calcipenic symptoms. Serum calcium improved over time from baseline- 7. 4mg/dl to 8. 7mg/dl at 1 year to 9. 2mg/dl at 5 years. As expected, these patients required higher doses of calcium and calcitriol. They required a calcium dose (mg/kg/d) of 138(70-160), which reduced to 100(42-200). Similarly, calcitriol dose (ng/kg/d) reduced from 75(50-100) to 62(27-100). Time to biochemical improvement was 5. 5 and 12months for VDDR1A and VDDR2 respectively. Additionally, two siblings with VDDR1B presented in their infancy, with complete biochemical response (alkaline phosphatase, serum parathyroid hormone, serum calcium) in 3 months with adequate calcium and vitamin D supplementation.

ALPPTHHypocalcemiaTreatment
VDDR1A(duration in months)(duration in months)Calcium dose(mg/kg/d)Calcitriol dose(ng/kg/d)
Our studyn = 65. 55. 54Baseline&unixF0E0; 62. 5 1 year&unixF0E0;55 5 years&unixF0E0;20Baseline&unixF0E0;40 1 year&unixF0E0;33. 5 5 years&unixF0E0;15
Manjunath H D et al (2021)n = 712-1512-153-6
Fatma Dursun et al (2019)n = 114-124-12NA
T Edouard et al (2011)n = 7333Initiated Calictriol at 1ug/d
VDDR2
Our studyn = 712129Baseline&unixF0E0; 138 1 year&unixF0E0;110 5 years&unixF0E0;105Baseline&unixF0E0;75 1 year&unixF0E0;70 5 years&unixF0E0;22. 5
Z Hochberg et al (1992)n = 1012121 week-IV calcium
Aida Al-Aqeel et al (1993)n = 21. 5-21. 5-23 days-IV calcium

Conclusion: Timely diagnosis of VDDR is lacking, but good symptomatic and biochemical response is seen once diagnosed and appropriately treated.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches